ANN STRAZDUS: Open Payments
NPI 1063509669 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 85 payments from 14 companies in 2025. Trend: 2023 $2,006 · 2024 $2,200 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 8 | $403 |
| ABBVIE INC. | 14 | $246 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $182 |
| Madrigal Pharmaceuticals | 11 | $175 |
| Phathom Pharmaceuticals, Inc. | 3 | $156 |
| Janssen Biotech, Inc. | 11 | $143 |
| Aimmune Therapeutics, Inc. | 9 | $141 |
| Ferring Pharmaceuticals Inc. | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| Gilead Sciences, Inc. | 2 | $57 |
Products named: IBSRELA, XIFAXAN, REZDIFFRA, RINVOQ, VOQUEZNA, TREMFYA, ZENPEP, DUPIXENT.
Industry payments across PA — which companies pay providers there.
